Reflections on the Innovative Medicines Initiative (vol 10, pg 321, 2011)

被引:0
|
作者
Goldman, Michel
机构
关键词
D O I
10.1038/nrd3479
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Nature Reviews Drug Discovery 10, 321–322 (2011) | doi:10.1038/nrd3434 A disclaimer has been added to the online version of the article to note that neither the European Commission nor the European Federation of Pharmaceutical Industries and Associations are affiliated with the publication, and thatthe opinions expressed in the article do not necessarily reflect their positions or opinions as founding members of the Innovative Medicines Initiative Joint Undertaking.
引用
收藏
页码:475 / 475
页数:1
相关论文
共 50 条
  • [1] Reflections on the Innovative Medicines Initiative
    Goldman, Michel
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (05) : 321 - 322
  • [2] Reflections on the Innovative Medicines Initiative
    Michel Goldman
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 321 - 322
  • [3] Erratum: Reflections on the Innovative Medicines Initiative
    Michel Goldman
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 471 - 471
  • [4] Will the Innovative Medicines Initiative really deliver innovative medicines?
    Wilkinson, Emma
    [J]. MOLECULAR ONCOLOGY, 2008, 2 (03) : 203 - 205
  • [5] INNOVATIVE MEDICINES INITIATIVE: THE SPRINTT PROJECT
    Marzetti, E.
    Calvani, R.
    Landi, F.
    Hoogendijk, E.
    Fougere, B.
    Vellas, B.
    Pahor, M.
    Bernabei, R.
    Cesari, M.
    [J]. JOURNAL OF FRAILTY & AGING, 2015, 4 (04): : 207 - 208
  • [6] Innovative Medicines Initiative and antibiotic resistance
    Kostyanev, Tarnishiv
    Bonten, Marc J. M.
    O'Brien, Seamus
    Goossens, Herman
    [J]. LANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1373 - 1375
  • [7] The Innovative Medicines Initiative-10 Years of Public-Private Collaboration
    Laverty, Hugh
    Meulien, Pierre
    [J]. FRONTIERS IN MEDICINE, 2019, 6
  • [8] Reflections on transparency (vol 12, pg 439, 2011)
    Ghaye, Tony
    [J]. REFLECTIVE PRACTICE, 2011, 12 (05) : 695 - 701
  • [9] Benchmarking the scientific output of the Innovative Medicines Initiative
    Gunn, Magda
    Lim, Mark
    Cross, Didi
    Goldman, Michel
    [J]. NATURE BIOTECHNOLOGY, 2015, 33 (08) : 811 - 812
  • [10] The Innovative Medicines Initiative: an engine for regulatory science
    Michel Goldman
    Nathalie Seigneuret
    Hans-Georg Eichler
    [J]. Nature Reviews Drug Discovery, 2015, 14 : 1 - 2